{
    "clinical_study": {
        "@rank": "112649", 
        "arm_group": [
            {
                "arm_group_label": "Coenzyme Q10/CC group", 
                "arm_group_type": "Experimental", 
                "description": "Intervention:\nCoenzyme Q10 (CoQ10) and clomiphene citrate group (55 patients, 82 cycles) Patients in CoQ10/CC group took CC (Global Napi, Cairo, Egypt) 100 mg/day from cycle days 2-6, and CoQ10  Mepaco, Enshas Elraml, Sharkhia,  Egypt), in a dose of 60 mg 3 times day capsules orally starting on cycle day 2 and continued till the day of human chorionic gonadotropin (hCG) administration"
            }, 
            {
                "arm_group_label": "CC alone group", 
                "arm_group_type": "Active Comparator", 
                "description": "Intervention:\nCC (Global Napi, Cairo, Egypt) 100 mg/day from cycle days 2-6"
            }
        ], 
        "brief_summary": {
            "textblock": "Objective of the study was to evaluate the effect of combination of oral Coenzyme Q10\n      (CoQ10), with clomiphene citrate (CC) for ovulation induction in CC-resistant polycystic\n      ovary syndrome (PCOS).In a prospective controlled randomized trial performed in a university\n      hospital and private practice setting. One hundred ten infertile women with PCOS resistant\n      to CC were randomized to either combined CC/CoQ10 (51 patients, 82 cycles) or CC 150 mg/day\n      alone (50 patients, 71 cycles) for ovulation induction in patients with CC-resistant PCOS.\n\n      Main outcome measures: Number of follicles, serum E2, serum P, endometrial thickness,\n      pregnancy rate (PR) and miscarriage rate."
        }, 
        "brief_title": "Coenzyme Q10 and Clomiphene Citrate (CC) for Ovulation Induction in Polycystic Ovary Syndrome", 
        "completion_date": {
            "#text": "January 2013", 
            "@type": "Actual"
        }, 
        "condition": "Polycystic Ovary Syndrome", 
        "condition_browse": {
            "mesh_term": "Polycystic Ovary Syndrome"
        }, 
        "detailed_description": {
            "textblock": "No more details"
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n          -  Diagnosis of PCOS based on the revised 2003 consensus on diagnostic criteria and\n             long-term health risks related to PCOS (2003).\n\n          -  All women were previously treated with 100 mg of CC daily for 5 days per cycle, for\n             two to three cycles with persistent anovulation or ovulate with very thin endometrium\n             <5 mm at the time of hCG administration\n\n        Exclusion Criteria:\n\n          -  patients with hyperprolactinaemia,\n\n          -  hypercorticism and\n\n          -  thyroid dysfunction.\n\n          -  patients receiving medications as cholesterol lowering drugs, as statins,\n             beta-blockers, and tricyclic antidepressants"
            }, 
            "gender": "Female", 
            "healthy_volunteers": "No", 
            "maximum_age": "N/A", 
            "minimum_age": "N/A"
        }, 
        "enrollment": {
            "#text": "110", 
            "@type": "Actual"
        }, 
        "firstreceived_date": "July 19, 2013", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT01910766", 
            "org_study_id": "CoQ10"
        }, 
        "intervention": [
            {
                "arm_group_label": "Coenzyme Q10/CC group", 
                "description": "no more details", 
                "intervention_name": "Coenzyme Q10", 
                "intervention_type": "Drug", 
                "other_name": "CC 100 mg/day 2-6 and CoQ10,60 mg 3 times day orally on day 2 till hCG"
            }, 
            {
                "arm_group_label": [
                    "Coenzyme Q10/CC group", 
                    "CC alone group"
                ], 
                "intervention_name": "clomiphene citrate", 
                "intervention_type": "Drug"
            }
        ], 
        "intervention_browse": {
            "mesh_term": [
                "Citric Acid", 
                "Clomiphene", 
                "Coenzyme Q10", 
                "Ubiquinone"
            ]
        }, 
        "is_fda_regulated": "No", 
        "keyword": [
            "pcos", 
            "coenzymeQ10", 
            "clomiphene citrate"
        ], 
        "lastchanged_date": "July 29, 2013", 
        "location": {
            "facility": {
                "address": {
                    "city": "Mansoura", 
                    "country": "Egypt", 
                    "state": "Dakahlia", 
                    "zip": "35111"
                }, 
                "name": "Mansoura University Hospitals"
            }
        }, 
        "location_countries": {
            "country": "Egypt"
        }, 
        "number_of_arms": "2", 
        "official_title": "Combined Coenzyme Q10 and Clomiphene Citrate (CC) for Ovulation Induction in CC-resistant Patients With Polycystic Ovary Syndrome", 
        "other_outcome": {
            "measure": "Number of miscarriages", 
            "safety_issue": "No", 
            "time_frame": "1 month"
        }, 
        "overall_status": "Completed", 
        "oversight_info": {
            "authority": "Egypt: Institutional Review Board", 
            "has_dmc": "No"
        }, 
        "phase": "N/A", 
        "primary_completion_date": {
            "#text": "January 2013", 
            "@type": "Actual"
        }, 
        "primary_outcome": {
            "measure": "Number of ovulating patients", 
            "safety_issue": "No", 
            "time_frame": "1-2 months"
        }, 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT01910766"
        }, 
        "responsible_party": {
            "investigator_affiliation": "Mansoura University", 
            "investigator_full_name": "ahmed M. badawy", 
            "investigator_title": "Professor of Obstetrics & Gynecology", 
            "responsible_party_type": "Principal Investigator"
        }, 
        "secondary_outcome": {
            "measure": "Number of pregnancies", 
            "safety_issue": "Yes", 
            "time_frame": "1-2 months"
        }, 
        "source": "Mansoura University", 
        "sponsors": {
            "lead_sponsor": {
                "agency": "Mansoura University", 
                "agency_class": "Other"
            }
        }, 
        "start_date": "January 2010", 
        "study_design": "Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Parallel Assignment, Masking: Single Blind (Investigator), Primary Purpose: Treatment", 
        "study_type": "Interventional", 
        "verification_date": "July 2013"
    }
}